AAPL307.92+13.54 (+4.60%) ▲|ABBV258.75+7.69 (+3.06%) ▲|ABT95.06+2.88 (+3.12%) ▲|ACN137.59+6.46 (+4.93%) ▲|ADBE221.29+10.31 (+4.89%) ▲|AMAT582.22-68.69 (-10.55%) ▼|AMD508.29-32.59 (-6.03%) ▼|AMGN370.97+9.64 (+2.67%) ▲|AMT167.10+1.02 (+0.61%) ▲|AMZN244.18+2.48 (+1.02%) ▲|AVGO358.48-10.86 (-2.94%) ▼|AXP349.14+2.09 (+0.60%) ▲|BA223.36+4.78 (+2.19%) ▲|BAC58.41+0.05 (+0.08%) ▲|BKNG182.11-0.53 (-0.29%) ▼|BLK990.65+10.27 (+1.05%) ▲|BMY57.13+1.32 (+2.36%) ▲|BNY145.30-0.72 (-0.49%) ▼|BRK-B505.86+6.12 (+1.22%) ▲|C138.41-1.72 (-1.23%) ▼|CAT952.74-38.67 (-3.90%) ▼|CL94.85+2.09 (+2.25%) ▲|CMCSA23.33-0.41 (-1.71%) ▼|COF203.34-1.48 (-0.72%) ▼|COP103.65+0.43 (+0.41%) ▲|COST948.52+23.85 (+2.58%) ▲|CRM165.63+2.40 (+1.47%) ▲|CSCO112.42-4.60 (-3.93%) ▼|CVS103.51-1.30 (-1.24%) ▼|CVX168.28+2.59 (+1.56%) ▲|DE616.89-10.75 (-1.71%) ▼|DHR196.52+2.80 (+1.45%) ▲|DIS98.04+2.33 (+2.43%) ▲|DUK128.25+2.48 (+1.97%) ▲|EMR137.50-2.02 (-1.45%) ▼|FDX311.28-2.61 (-0.83%) ▼|GD369.77+8.50 (+2.35%) ▲|GE374.86-0.08 (-0.02%) ▼|GEV1,096.07-38.29 (-3.38%) ▼|GILD129.82+3.85 (+3.05%) ▲|GM74.40-1.12 (-1.49%) ▼|GOOG353.34-4.55 (-1.27%) ▼|GOOGL356.52-4.70 (-1.30%) ▼|GS1,011.89-7.73 (-0.76%) ▼|HD354.31+3.47 (+0.99%) ▲|HON226.01+4.26 (+1.92%) ▲|IBM285.80-0.45 (-0.16%) ▼|INTC119.47-7.55 (-5.94%) ▼|INTU275.16+8.08 (+3.03%) ▲|ISRG421.27+18.89 (+4.69%) ▲|JNJ261.48+7.50 (+2.95%) ▲|JPM332.72-1.35 (-0.40%) ▼|KO83.07+1.78 (+2.18%) ▲|LIN545.31+11.76 (+2.20%) ▲|LLY1,207.93+16.19 (+1.36%) ▲|LMT537.11+15.29 (+2.93%) ▲|LOW224.59+2.67 (+1.20%) ▲|LRCX346.53-44.73 (-11.43%) ▼|MA536.68+14.24 (+2.73%) ▲|MCD278.21+8.78 (+3.26%) ▲|MDLZ60.43+1.08 (+1.82%) ▲|MDT82.49+3.29 (+4.15%) ▲|META584.66-28.25 (-4.61%) ▼|MMM159.84-0.13 (-0.08%) ▼|MO72.28+0.74 (+1.03%) ▲|MRK128.13+2.76 (+2.20%) ▲|MS212.02+0.16 (+0.08%) ▲|MSFT390.75+6.47 (+1.68%) ▲|MU962.11-70.17 (-6.80%) ▼|NEE87.29+0.92 (+1.06%) ▲|NFLX78.19+4.00 (+5.39%) ▲|NKE43.95+0.89 (+2.07%) ▲|NOW106.02+0.22 (+0.21%) ▲|NVDA193.10-4.48 (-2.27%) ▼|ORCL139.27-3.23 (-2.27%) ▼|PEP143.74+2.58 (+1.83%) ▲|PFE24.28+0.40 (+1.65%) ▲|PG151.04+3.61 (+2.45%) ▲|PLTR131.35+5.62 (+4.47%) ▲|PM180.47+2.78 (+1.56%) ▲|QCOM173.30-8.62 (-4.74%) ▼|RTX196.72+4.94 (+2.58%) ▲|SBUX104.01+0.62 (+0.60%) ▲|SCHW96.54+0.76 (+0.79%) ▲|SO97.26+2.14 (+2.25%) ▲|SPG224.69+1.69 (+0.76%) ▲|T20.12-0.37 (-1.78%) ▼|TMO520.06+6.73 (+1.31%) ▲|TMUS174.81+1.75 (+1.01%) ▲|TSLA392.09-33.22 (-7.81%) ▼|TXN289.85-8.57 (-2.87%) ▼|UBER73.36+0.70 (+0.96%) ▲|UNH422.34-4.20 (-0.98%) ▼|UNP280.32+2.59 (+0.93%) ▲|UPS109.48-0.07 (-0.06%) ▼|USB61.30-0.66 (-1.07%) ▼|V359.66+8.58 (+2.44%) ▲|VZ41.48-0.52 (-1.23%) ▼|WFC85.18-0.76 (-0.88%) ▼|WMT111.84+3.02 (+2.77%) ▲|XOM136.93+0.65 (+0.48%) ▲|AAPL307.92+13.54 (+4.60%) ▲|ABBV258.75+7.69 (+3.06%) ▲|ABT95.06+2.88 (+3.12%) ▲|ACN137.59+6.46 (+4.93%) ▲|ADBE221.29+10.31 (+4.89%) ▲|AMAT582.22-68.69 (-10.55%) ▼|AMD508.29-32.59 (-6.03%) ▼|AMGN370.97+9.64 (+2.67%) ▲|AMT167.10+1.02 (+0.61%) ▲|AMZN244.18+2.48 (+1.02%) ▲|AVGO358.48-10.86 (-2.94%) ▼|AXP349.14+2.09 (+0.60%) ▲|BA223.36+4.78 (+2.19%) ▲|BAC58.41+0.05 (+0.08%) ▲|BKNG182.11-0.53 (-0.29%) ▼|BLK990.65+10.27 (+1.05%) ▲|BMY57.13+1.32 (+2.36%) ▲|BNY145.30-0.72 (-0.49%) ▼|BRK-B505.86+6.12 (+1.22%) ▲|C138.41-1.72 (-1.23%) ▼|CAT952.74-38.67 (-3.90%) ▼|CL94.85+2.09 (+2.25%) ▲|CMCSA23.33-0.41 (-1.71%) ▼|COF203.34-1.48 (-0.72%) ▼|COP103.65+0.43 (+0.41%) ▲|COST948.52+23.85 (+2.58%) ▲|CRM165.63+2.40 (+1.47%) ▲|CSCO112.42-4.60 (-3.93%) ▼|CVS103.51-1.30 (-1.24%) ▼|CVX168.28+2.59 (+1.56%) ▲|DE616.89-10.75 (-1.71%) ▼|DHR196.52+2.80 (+1.45%) ▲|DIS98.04+2.33 (+2.43%) ▲|DUK128.25+2.48 (+1.97%) ▲|EMR137.50-2.02 (-1.45%) ▼|FDX311.28-2.61 (-0.83%) ▼|GD369.77+8.50 (+2.35%) ▲|GE374.86-0.08 (-0.02%) ▼|GEV1,096.07-38.29 (-3.38%) ▼|GILD129.82+3.85 (+3.05%) ▲|GM74.40-1.12 (-1.49%) ▼|GOOG353.34-4.55 (-1.27%) ▼|GOOGL356.52-4.70 (-1.30%) ▼|GS1,011.89-7.73 (-0.76%) ▼|HD354.31+3.47 (+0.99%) ▲|HON226.01+4.26 (+1.92%) ▲|IBM285.80-0.45 (-0.16%) ▼|INTC119.47-7.55 (-5.94%) ▼|INTU275.16+8.08 (+3.03%) ▲|ISRG421.27+18.89 (+4.69%) ▲|JNJ261.48+7.50 (+2.95%) ▲|JPM332.72-1.35 (-0.40%) ▼|KO83.07+1.78 (+2.18%) ▲|LIN545.31+11.76 (+2.20%) ▲|LLY1,207.93+16.19 (+1.36%) ▲|LMT537.11+15.29 (+2.93%) ▲|LOW224.59+2.67 (+1.20%) ▲|LRCX346.53-44.73 (-11.43%) ▼|MA536.68+14.24 (+2.73%) ▲|MCD278.21+8.78 (+3.26%) ▲|MDLZ60.43+1.08 (+1.82%) ▲|MDT82.49+3.29 (+4.15%) ▲|META584.66-28.25 (-4.61%) ▼|MMM159.84-0.13 (-0.08%) ▼|MO72.28+0.74 (+1.03%) ▲|MRK128.13+2.76 (+2.20%) ▲|MS212.02+0.16 (+0.08%) ▲|MSFT390.75+6.47 (+1.68%) ▲|MU962.11-70.17 (-6.80%) ▼|NEE87.29+0.92 (+1.06%) ▲|NFLX78.19+4.00 (+5.39%) ▲|NKE43.95+0.89 (+2.07%) ▲|NOW106.02+0.22 (+0.21%) ▲|NVDA193.10-4.48 (-2.27%) ▼|ORCL139.27-3.23 (-2.27%) ▼|PEP143.74+2.58 (+1.83%) ▲|PFE24.28+0.40 (+1.65%) ▲|PG151.04+3.61 (+2.45%) ▲|PLTR131.35+5.62 (+4.47%) ▲|PM180.47+2.78 (+1.56%) ▲|QCOM173.30-8.62 (-4.74%) ▼|RTX196.72+4.94 (+2.58%) ▲|SBUX104.01+0.62 (+0.60%) ▲|SCHW96.54+0.76 (+0.79%) ▲|SO97.26+2.14 (+2.25%) ▲|SPG224.69+1.69 (+0.76%) ▲|T20.12-0.37 (-1.78%) ▼|TMO520.06+6.73 (+1.31%) ▲|TMUS174.81+1.75 (+1.01%) ▲|TSLA392.09-33.22 (-7.81%) ▼|TXN289.85-8.57 (-2.87%) ▼|UBER73.36+0.70 (+0.96%) ▲|UNH422.34-4.20 (-0.98%) ▼|UNP280.32+2.59 (+0.93%) ▲|UPS109.48-0.07 (-0.06%) ▼|USB61.30-0.66 (-1.07%) ▼|V359.66+8.58 (+2.44%) ▲|VZ41.48-0.52 (-1.23%) ▼|WFC85.18-0.76 (-0.88%) ▼|WMT111.84+3.02 (+2.77%) ▲|XOM136.93+0.65 (+0.48%) ▲|
37.8 C
New York
Thursday, July 2, 2026

Tag: patients

newssourceFORcompanyinformationcontent1releasesmarket

Cooper Aerobics Partners with Parker University

Cooper Aerobics announces a partnership with Parker University, bringing medically validated CooperFit™ cardiovascular fitness test to two Parker clinics.

PlushCare Launches Enhanced Online Weight Loss Program to Expand National Access to GLP-1 Prescriptions Through Board-Certified Doctors

Secure Online Access to GLP-1 Weight Loss Medications Like Semaglutide Now Available Nationwide Through PlushCare’s Updated Virtual Health Platform 
Secure Online Access to GLP-1 Weight Loss Medications Like Semaglutide Now Available Nationwide Through PlushCare’s Updated Virtual Health Platform

Children With Acute Allergic Reactions Often Spend Unnecessary Time in Hospitals

While many children experiencing anaphylaxis stay for long hours, even overnight, after receiving a dose of epinephrine, 95% could be safely discharged within 2...

Enhance.MD Launches Nationwide Telehealth Expansion to Support Men’s Hormonal Health and Medically Supervised Weight Loss

Virtual platform now offers licensed physician care for testosterone therapy, GLP-1 weight loss support, and men’s wellness programs across all 50 U.S. states 
Virtual platform now offers licensed physician care for testosterone therapy, GLP-1 weight loss support, and men’s wellness programs across all 50 U.S. states

argenx Presents New Efgartigimod Data at EULAR 2025 Highlighting Positive Phase 2 Proof-of-Concept Results in Myositis and Sjogren’s Disease

June 11, 2025, 12:01 AM CET

Parkview Health patients share heartwarming “thank you” with caregivers in new brand campaign

Patients and their families surprise doctors to express gratitude for life-saving care  FORT WAYNE, Ind., June 10, 2025 /PRNewswire/ -- Parkview Health today launched its most...

Philochem AG Announces the Licensing of Worldwide Rights to OncoACP3, a novel Radiopharmaceutical Therapeutic and Diagnostic Agent targeting Prostate Cancer, to RayzeBio, a Bristol-Myers...

Philochem Licensing of OncoACP3 to RayzeBio for potential value of up to $1.35bn plus royalties

ReflexMD Expands Digital Health Access Nationwide with Seamless Prescription Experience

Telehealth Platform Offers Nationwide Access to Licensed Providers for Weight Management, Hair Loss, and Wellness Care From Home 
Telehealth Platform Offers Nationwide Access to Licensed Providers for Weight Management, Hair Loss, and Wellness Care From Home

Growth Hormone Deficiency Market to Register Incremental Growth at a CAGR of 5.7% During the Forecast Period (2025-2034) | DelveInsight

The growth hormone deficiency market is expected to see expansion across the 7MM driven by the introduction of innovative therapies, including LUM-201 and SCO-240,...

BioAegis Therapeutics Announces US Navy Contract to Support Phase 2 Study of Recombinant Human Gelsolin, for Inflammasome-Driven Decompression Sickness (DCS)

Phase 2 proof-of-concept study for rhu-pGSN, a promising intervention across a spectrum of inflammatory diseases, to be studied as an intervention for the negative outcomes of decompression in SCUBA Divers 
Phase 2 proof-of-concept study for rhu-pGSN, a promising intervention across a spectrum of inflammatory diseases, to be studied as an intervention for the negative outcomes of decompression in SCUBA Divers

Anesthesia Patient Safety Foundation Hosts Capitol Hill Briefing to Urge Adoption of Continuous Blood Pressure Monitoring as Standard of Care

WASHINGTON, June 10, 2025 /PRNewswire/ -- Today, the Anesthesia Patient Safety Foundation (APSF) proudly hosted a Capitol Hill briefing, highlighting the critical need to...

Nuwellis Announces Closing of $5.0 Million Underwritten Public Offering Including Full Exercise of Overallotment Option

MINNEAPOLIS, June 10, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE) (“Nuwellis” or the “Company”), a commercial-stage medical device company dedicated to transforming care for fluid overload patients, today announced the closing of a public offering of 2,580,667 shares of its common stock (“Common Stock”), pre-funded warrants to purchase 14,085,998 shares of Common Stock, in each case with accompanying Series A Warrants to purchase up to 49,999,995 shares of Common Stock and Series B Warrants to purchase up to 16,666,665 shares of Common Stock with gross proceeds of approximately $5.0 million, which includes the full exercise of the underwriter’s over-allotment option to purchase additional shares and warrants.

lllumina releases 2024 Corporate Social Responsibility Report as it advances its vision to unlock the power of genomics

SAN DIEGO, June 10, 2025 /PRNewswire/ -- Illumina Inc. (NASDAQ: ILMN), aligned with its commitments to advance the power of genomics, today published its...

Applied Medical Technology, Inc. Unveils Redesigned Mobile App Aligned with Recent Website Refresh

BRECKSVILLE, Ohio., June 10, 2025 /PRNewswire/ -- Applied Medical Technology, Inc. (AMT), a leader in innovative medical devices, is proud to announce the launch of...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsPatients

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers